Status:

Red

Decision Date:

March 2023

Comments

Treatment of adults with relapsed and refractory multiple myeloma. NHSE commissioned.

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again